Description

(1S)-1,2,3,3A,5Aβ,6,10B,10Cβ-Octahydro-1,2α,6α-Trihydroxy-3Aβ,10Bα-Dimethyl-7-Isopropyl-4H,9H-Furo[2',3',4':4,5]Naphtho[2,1-C]Pyran-4,9-Dione is a complex, high-purity organic compound characterized by its intricate fused-ring structure. This compound is of significant interest in advanced chemical synthesis and research due to its potential as a key intermediate or scaffold for developing novel active molecules. It is primarily sought by pharmaceutical research organizations, fine chemical manufacturers, and academic institutions engaged in medicinal chemistry and process development.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, particularly in oncology and anti-infective research.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and library synthesis.
• Fine Chemical Synthesis: Acts as a precursor for the production of complex natural product analogs and specialty chemicals.
• Biochemical Research: Potential utility as a probe or inhibitor in studying specific enzymatic pathways due to its unique stereochemistry.
• Process Development & Scale-up: Employed in optimizing synthetic routes for the commercial production of high-value compounds.

Basic Information

Product Name	(1S)-1,2,3,3A,5Aβ,6,10B,10Cβ-Octahydro-1,2α,6α-Trihydroxy-3Aβ,10Bα-Dimethyl-7-Isopropyl-4H,9H-Furo[2',3',4':4,5]Naphtho[2,1-C]Pyran-4,9-Dione
CAS No.	19891-51-1
Molecular Formula	C22H28O7
Molecular Weight	404.46 g/mol
Synonyms	Furo[2',3',4':4,5]naphtho[2,1-c]pyran-4,9-dione, 1,2,3,3a,5aβ,6,10b,10cβ-octahydro-1,2α,6α-trihydroxy-3aβ,10bα-dimethyl-7-(1-methylethyl)-, (1S)-; 7-Isopropyl-1,2,3,3a,5aβ,6,10b,10cβ-octahydro-1,2α,6α-trihydroxy-3aβ,10bα-dimethylfuro[2',3',4':4,5]naphtho[2,1-c]pyran-4,9-dione; Complex Furanonaphthopyrandione derivative; (1S)-Octahydrotrihydroxydimethylisopropylfuronaphthopyrandione. Contact for additional trade names or abbreviations.
EINECS	Contact for details

Quality Control

We supply this advanced intermediate under a rigorous quality management system. Each batch is characterized and tested to ensure identity, purity, and consistency suitable for research and development applications. A comprehensive Certificate of Analysis (COA) is provided with each shipment, detailing key analytical results including assay by HPLC, chiral purity, and identification by spectroscopic methods (NMR, IR). Our quality protocols are designed to meet the exacting standards of pharmaceutical R&D and fine chemical synthesis.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). For long-term storage, consider holding under inert atmosphere to preserve stability. Keep the container sealed to prevent moisture absorption and contamination.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (NMR)	Conforms to structure
Assay (HPLC)	≥ 97.0%
Chiral Purity (Chiral HPLC)	≥ 98.0% ee
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.